They need to amend page 18 and remove the reference to CSL 112 as a candidate product currently in phase III trials.
Just highlight and delete.
Ann: Shareholder Information Meetings, page-4
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$285.86 |
Change
3.860(1.37%) |
Mkt cap ! $138.1B | |||
| Open | High | Low | Value | Volume |
| $284.20 | $286.44 | $283.73 | $264.9M | 927.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 550 | $285.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $285.90 | 300 | 1 |
View Market Depth
| Last trade - 16.10pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$285.74 |
Change
3.860 ( 1.24 %) |
||||
| Open | High | Low | Volume | ||
| $284.10 | $286.45 | $283.86 | 73375 | ||
| Last updated 15.59pm 05/06/2024 ? | |||||
| CSL (ASX) Chart |